Black Diamond Therapeutics (BDTX) Other Non-Current Assets (2018 - 2026)

Black Diamond Therapeutics (BDTX) has reported Other Non-Current Assets for 9 consecutive years, with $833000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Non-Current Assets rose 1.09% year-over-year to $833000.0; the trailing twelve-month figure through Jun 2026 stood at $833000.0 (up 1.09% YoY), and the FY2025 full-year result was $829000.0, up 1.22% from the prior year.
• Other Non-Current Assets steadied at $833000.0 in Q2 2026 per BDTX's latest filing, from $831000.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $1.2 million in Q2 2023 and bottomed at $819000.0 in Q3 2023.
• Historically, Other Non-Current Assets has averaged $945333.3 across 5 years, with a median of $828000.0 in 2025.
• The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets rose 5.14% in 2023, then sank 33.06% in 2024.
• Over 5 years, Other Non-Current Assets stood at $1.2 million in 2022, then slipped by 29.54% to $823000.0 in 2023, then retreated by 0.49% to $819000.0 in 2024, then climbed by 1.22% to $829000.0 in 2025, then grew by 0.48% to $833000.0 in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $833000.0, $831000.0, and $829000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.